<div id="readability-page-1"><p>OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) Director Thomas Kosasa purchased 280,898 shares of the stock in a transaction dated Thursday, April 23rd. The stock was bought at an average cost of $0.89 per share, with a total value of $249,999.22. Following the transaction, the director owned 16,661,327 shares in the company, valued at $14,828,581.03. The trade was a 1.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website.</p><ul><li>Palantir’s New Healthcare Deal Boosts AI and Data Reach </li></ul><p>Thomas Kosasa also recently made the following trade(s): </p><ul><li>On Friday, February 6th, Thomas Kosasa purchased 595,238 shares of OneMedNet stock. The stock was bought at an average cost of $0.84 per share, with a total value of $499,999.92. </li></ul><h2>OneMedNet Stock Performance</h2><p>Shares of ONMD traded up $0.21 during trading hours on Friday, hitting $1.10. The company had a trading volume of 821,198 shares, compared to its average volume of 3,251,295. The firm has a fifty day moving average price of $0.79 and a 200-day moving average price of $1.26. The stock has a market capitalization of $57.58 million, a price-to-earnings ratio of -15.76 and a beta of 1.16. OneMedNet Corporation has a 52-week low of $0.31 and a 52-week high of $4.22. </p><p>OneMedNet (NASDAQ:ONMD - Get Free Report) last posted its quarterly earnings results on Monday, March 30th. The company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $0.89 million during the quarter. </p><h2>Institutional Investors Weigh In On OneMedNet</h2><p>Several large investors have recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in  OneMedNet in the 4th quarter worth about $48,000.  State Street Corp increased its holdings in  OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company's stock worth $128,000 after buying an additional 34,200 shares in the last quarter.  Jane Street Group LLC bought a new stake in  OneMedNet in the 4th quarter worth about $119,000.  HRT Financial LP bought a new stake in  OneMedNet in the 4th quarter worth about $32,000.  Finally, Exencial Wealth Advisors LLC increased its holdings in  OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company's stock worth $4,009,000 after buying an additional 45,401 shares in the last quarter. 0.95% of the stock is currently owned by institutional investors. </p><h2>Analysts Set New Price Targets</h2><p>Separately, Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of OneMedNet in a research report on Friday, January 9th. One equities research analyst  has rated the stock with a Sell rating,  According to MarketBeat.com, OneMedNet  has an average rating of &#34;Sell&#34;.</p><p><b>View Our Latest Analysis on OneMedNet</b></p><h2>OneMedNet Company Profile</h2> (Get Free Report)<p>OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota. </p><h2>Featured Articles</h2><ul><li>Five stocks we like better than OneMedNet</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T05NRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T05NRA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in OneMedNet Right Now?</h2><p>Before you consider OneMedNet, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OneMedNet wasn't on the list.</p><p>While OneMedNet currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ONMD

LABU

SBIO

<p>OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 280,898 shares at $0.89 each, totaling $249,999.22, on April 23rd. This acquisition increased his ownership by 1.71%, bringing his total to 16,661,327 shares valued at approximately $14.83 million. The transaction was disclosed to the SEC. The stock recently traded at $1.10, with a market cap of $57.58 million and a 52-week range of $0.31 to $4.22. Analysts maintain a "sell" rating on the stock, with institutional investors holding 0.95% of shares.</p>

OneMedNet (NASDAQ:ONMD) Director Thomas Kosasa Buys 280,898 Shares